{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:27:36Z","timestamp":1756996056988,"version":"3.40.4"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Inflammation is an important factor in the development of cardiac injury during and after percutaneous coronary intervention (PCI). Vitamin D receptors play a significant role in the cardiovascular system and have anti-inflammatory effects. Hence, our goal was to evaluate the impact of calcitriol and cholecalciferol as vitamin D receptors agonists on inflammatory biomarkers in patients who are undergoing elective PCI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this controlled clinical trial, patients undergoing elective PCI were randomly assigned to receive either calcitriol and cholecalciferol or were placed in the control group from July 2021 to November 2022. Calcitriol and cholecalciferol were administered at doses of 1 mcg and 300,000 international units, respectively, before the procedure. High-sensitive C-reactive protein (hs-CRP) was evaluated as the main inflammatory biomarker and other relevant clinical and laboratory data were also included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>During the study, 180 patients were allocated into three groups, each consisting of 60 patients, with a mean age of 62.26\u2005\u00b1\u20058.73 years. The prevalence of the underlying conditions was not different among the groups. After 24 hours, hs-CRP levels were lower (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.012), and a significantly lower increase from baseline was observed (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.003) in the group that received calcitriol. However, no significant differences were observed in Troponin I and creatine kinase-MB levels (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Administration of calcitriol was associated with significantly lower levels of hs-CRP, the main cardiac inflammatory marker, in patients undergoing elective PCI. Further clinical studies with a larger sample size are needed to assess the clinical impact of this anti-inflammatory effect.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000042103","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:00:52Z","timestamp":1744664452000},"page":"e42103","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The effect of calcitriol and cholecalciferol on inflammatory markers in periprocedural myocardial injury: A randomized controlled trial"],"prefix":"10.1097","volume":"104","author":[{"given":"Laleh","family":"Mahmoudi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peyman","family":"Izadpanah","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0322-8257","authenticated-orcid":false,"given":"Sara","family":"Asadi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250414","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacc.2007.06.022","article-title":"Coronary revascularization in the community: a population-based study, 1990 to 2004.","volume":"50","author":"Gerber","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250414","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/eurheartj\/ehaa885","article-title":"Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.","volume":"42","author":"Silvain","year":"2021","journal-title":"Eur Heart J"},{"key":"R3-20250414","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/ccd.22962","article-title":"Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis.","volume":"77","author":"Feldman","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"R4-20250414","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/hrt.2009.186189","article-title":"Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?","volume":"96","author":"Cuculi","year":"2010","journal-title":"Heart"},{"key":"R5-20250414","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction.","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R6-20250414","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.acvd.2016.04.002","article-title":"Inflammation in atherosclerosis.","volume":"109","author":"Taleb","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"R7-20250414","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.21037\/jtd-20-1605","article-title":"Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study.","volume":"12","author":"Zhao","year":"2020","journal-title":"J Thorac Dis"},{"key":"R8-20250414","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/ptr.7454","article-title":"The role of pycnogenol in the control of inflammation and oxidative stress in chronic diseases: molecular aspects.","volume":"36","author":"Nattagh-Eshtivani","year":"2022","journal-title":"Phytother Res"},{"key":"R9-20250414","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/fsn3.2684","article-title":"Does propolis have any effect on rheumatoid arthritis? A review study.","volume":"10","author":"Nattagh-Eshtivani","year":"2022","journal-title":"Food Sci Nutr"},{"key":"R10-20250414","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12986-023-00758-9","article-title":"The effect of conjugated linoleic acids on inflammation, oxidative stress, body composition and physical performance: a comprehensive review of putative molecular mechanisms.","volume":"20","author":"Putera","year":"2023","journal-title":"Nutr Metab (Lond)"},{"key":"R11-20250414","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCRESAHA.113.301241","article-title":"Vitamin D and cardiovascular disease.","volume":"114","author":"Norman","year":"2014","journal-title":"Circ Res"},{"key":"R12-20250414","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2016.06.067","article-title":"Vitamin D controls resistance artery function through regulation of perivascular adipose tissue hypoxia and inflammation.","volume":"98","author":"Pelham","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"R13-20250414","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice.","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"key":"R14-20250414","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2010.543","article-title":"Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease.","volume":"79","author":"Dusso","year":"2011","journal-title":"Kidney Int"},{"key":"R15-20250414","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-pharmtox-010510-100611","article-title":"Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.","volume":"51","author":"Krishnan","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R16-20250414","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/j.clnu.2020.11.037","article-title":"A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease.","volume":"40","author":"Mahmoudi","year":"2021","journal-title":"Clin Nutr"},{"key":"R17-20250414","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jcph.989","article-title":"Effect of vitamin D in the prevention of myocardial injury following elective percutaneous coronary intervention: a pilot randomized clinical trial.","volume":"58","author":"Aslanabadi","year":"2018","journal-title":"J Clin Pharmacol"},{"issue":"Suppl1","key":"R18-20250414","first-page":"282","article-title":"The potential effect of intravenous calcitriol on the ischemia-reperfusion process and inflammatory biomarkers in patients following percutaneous coronary intervention (PCI).","volume":"18","author":"Dastan","year":"2019","journal-title":"Iran J Pharm Res"},{"key":"R19-20250414","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3945\/ajcn.2008.26182","article-title":"Serum 25-hydroxyvitamin D status of the US population: 1988\u20131994 compared with 2000\u20132004.","volume":"88","author":"Looker","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R20-20250414","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0260106018802968","article-title":"Prevalence of vitamin D deficiency in Iran: a systematic review and meta-analysis.","volume":"24","author":"Vatandost","year":"2018","journal-title":"Nutr Health"},{"key":"R21-20250414","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jn\/135.2.317","article-title":"Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D.","volume":"135","author":"Hollis","year":"2005","journal-title":"J Nutr"},{"key":"R22-20250414","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R23-20250414","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/01.CIR.94.3.279","article-title":"Platelet activation and coronary stent implantation: effect of antithrombotic therapy.","volume":"94","author":"Gawaz","year":"1996","journal-title":"Circulation"},{"key":"R24-20250414","first-page":"655","article-title":"The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome.","volume":"24","author":"Muschart","year":"2012","journal-title":"J Invasive Cardiol"},{"key":"R25-20250414","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.carrev.2020.04.011","article-title":"Periprocedural myocardial injury: pathophysiology, prognosis, and prevention.","volume":"21","author":"Soud","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"R26-20250414","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.3892\/etm.2016.3877","article-title":"Protective approaches against myocardial ischemia reperfusion injury.","volume":"12","author":"Li","year":"2016","journal-title":"Exp Ther Med"},{"key":"R27-20250414","doi-asserted-by":"crossref","first-page":"e12471","DOI":"10.1111\/jpi.12471","article-title":"Protective role of melatonin in cardiac ischemia\u2010reperfusion injury: From pathogenesis to targeted therapy.","volume":"64","author":"Zhou","year":"2018","journal-title":"J Pineal Res"},{"key":"R28-20250414","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association.","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"R29-20250414","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1093\/eurheartj\/ehl308","article-title":"Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology [5].","volume":"27","author":"Messerli","year":"2006","journal-title":"Eur Heart J"},{"key":"R30-20250414","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.atherosclerosis.2015.05.007","article-title":"The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.","volume":"241","author":"Vlachopoulos","year":"2015","journal-title":"Atherosclerosis"},{"key":"R31-20250414","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.55730\/1300-0144.5537","article-title":"Effect of vitamin D on myocardial remodeling and inflammatory status in children with congenital heart disease.","volume":"52","author":"G\u00f6kalp","year":"2022","journal-title":"Turk J Med Sci"},{"key":"R32-20250414","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cvr\/cvy034","article-title":"Vitamin D receptor restricts T helper 2-biased inflammation in the heart.","volume":"114","author":"Song","year":"2018","journal-title":"Cardiovasc Res"},{"key":"R33-20250414","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejvs.2012.06.023","article-title":"Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study.","volume":"44","author":"Stricker","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R34-20250414","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.3390\/ijms231911992","article-title":"A single oral vitamin D3 bolus reduces inflammatory markers in healthy Saudi Males.","volume":"23","author":"AlGhamdi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R35-20250414","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3390\/nu13041280","article-title":"Single high-dose vitamin D supplementation as an approach for reducing ultramarathon-induced inflammation: a double-blind randomized controlled trial.","volume":"13","author":"Mieszkowski","year":"2021","journal-title":"Nutrients"},{"key":"R36-20250414","doi-asserted-by":"crossref","first-page":"461","DOI":"10.14503\/THIJ-13-3466","article-title":"Inflammation and C-reactive protein in atrial fibrillation: cause or effect?","volume":"41","author":"Galea","year":"2014","journal-title":"Tex Heart Inst J"},{"key":"R37-20250414","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/biology7040049","article-title":"Therapeutic approaches targeting inflammation in cardiovascular disorders.","volume":"7","author":"Jones","year":"2018","journal-title":"Biology"},{"key":"R38-20250414","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.amjcard.2006.07.059","article-title":"Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.","volume":"99","author":"Gach","year":"2007","journal-title":"Am J Cardiol"},{"key":"R39-20250414","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18203\/2349-3933.ijam20180944","article-title":"Markers of inflammation following percutaneous coronary intervention (PCI) and its effect on adverse events.","volume":"5","author":"Kumar Mahesh","year":"2018","journal-title":"Int J Adv Med"},{"key":"R40-20250414","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0008-6363(03)00355-9","article-title":"Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention.","volume":"60","author":"Rahel","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R41-20250414","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874192401812010029","article-title":"Reduction of vascular inflammation, LDL-C, or both for the protection from cardiovascular events?","volume":"12","author":"Reklou","year":"2018","journal-title":"Open Cardiovasc Med J"},{"key":"R42-20250414","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jcin.2019.07.014","article-title":"Impact of periprocedural myocardial biomarker elevation on mortality following elective percutaneous coronary intervention.","volume":"12","author":"Garcia-Garcia","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"R43-20250414","first-page":"135","article-title":"Novel biomarkers for cardiovascular risk prediction.","volume":"14","author":"Wang","year":"2017","journal-title":"J GeriatrCardiol"},{"key":"R44-20250414","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jacc.2009.07.005","article-title":"Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.","volume":"54","author":"Briguori","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R45-20250414","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCULATIONAHA.110.002451","article-title":"Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies.","volume":"123","author":"Patti","year":"2011","journal-title":"Circulation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:00:58Z","timestamp":1744664458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":45,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042103","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]}}}